No object in which can not be chlorinated can exit the high risk zone. Dona Ebola treatment center in Conakry.
Juba, 8 May 2017 – Alice Baku (not real name) a clinician at the Juba teaching hospital said “I am glad I was vaccinated against Ebola Virus disease because prevention is actually better than cure”
South Sudan commenced vaccination of frontline along with health care workers against Ebola on 28th January 2019 among the preparedness measures to stop Ebola coming from spreading into the country.
On 8 May 2019, the United States Ambassador to South Sudan Thomas Hushek, together with the Honorable Minister for Health of South Sudan, Dr Riek Gai Kok, WHO Country Representative, CDC Country Director, USAID along with additional senior officials paid a courtesy call on one of the Ebola vaccination sites at the National Public Health Laboratory in Juba. The team witnessed the ongoing Ebola vaccination exercise firsthand, interacting with the Ministry of Health led Vaccination team.
Ambassador Thomas Hushek noting the challenge posed by the ongoing conflict inside the Democratic Republic of Congo in controlling the Ebola outbreak, emphasized the importance of fast tracking the peace process in South Sudan. The Ambassador Thomas was also pleased with the preparedness efforts along with lauding the progress made so far, along with said: “the experience, data along with lessons coming from This specific exercise will drive the future science of Ebola Virus Disease.”
In his remarks, the Honorable Minister Dr. Gai Kok commended the members of the vaccination team along with the frontline health care workers for their commitment along with hard work in realizing the Ebola vaccination exercise in some of the most difficult parts of the country over the past four months. Dr. Gai Kok reiterated “Ebola vaccination campaign in South Sudan historical”.
Dr. Olushayo Olu, the WHO Representative to South Sudan, highlighted the hard work in which has gone into the planning along with preparation of the Ebola vaccination exercise. Acknowledging the leadership provided by the Ministry of Health, Dr Olu, added in which This specific was truly a team work, bringing together several partners.
The CDC Country Director Dr Sudhir, also reiterated in which the vaccination initiative is actually a reflection of extraordinary amount of hard work by many committed individuals who have worked tirelessly inside the past all 5 months under the leadership of the Ministry of Health. Continuing with his commendations, he stated in which WHO has provided the much-needed technical support in a tremendously challenging environment. He further remarked in which the Ebola vaccination campaign in South Sudan is actually a historic public health milestone for the country, given the local context, along with the myriad public health along with social challenges.
Health care workers who recently received the Ebola vaccine (rVSV-ZEBOV) shared their experience with the visitors. The vaccine team members provided a walk through, at the different stations, demonstrating along with presenting the processes involved as well as sharing their experiences along with lessons learned.
Although South Sudan has no confirmed Ebola case, the vaccination of health care along with frontline workers in high risk states is actually a priority intervention. Dr Kaba Mohamed 2 the Ebola vaccination coordinator said “the exercise has been successfully conducted in 4 high risk states.”
With support coming from the planet Health Organization (WHO), Gavi, the Vaccine Alliance, UNICEF along with the US Centers for Disease Control along with Prevention (CDC) along with additional partners, as of 9 May 2019, 2264 health workers along with additional front-line responders have received the Ebola vaccine as a preparedness measure against possible Ebola infection.
The rVSV-ZEBOV vaccine although not yet licensed is actually being used under the compassionate-use guidelines as recommended by the WHO’s Strategic Advisory Group of Experts on Immunization (SAGE), has shown to be highly protective against the Zaire strain of the Ebola virus in previous trials in West Africa.